Dr. Bajor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3951Fax+1 216-844-5759
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2010 - 2013
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2010
- Case Western Reserve University School of MedicineClass of 2007
Certifications & Licensure
- OH State Medical License 2016 - 2025
- PA State Medical License 2007 - 2016
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer Start of enrollment: 2016 Sep 12
Publications & Presentations
PubMed
- 340 citationsTumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cellsAlbert C. Lo, Liang-Chuan S. Wang, John Scholler, James Monslow, Diana Avery
Cancer Research. 2015-07-15 - 393 citationsClinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal AntibodyRobert H. Vonderheide, Keith T. Flaherty, Magi Khalil, Molly S. Stumacher, David L. Bajor
Journal of Clinical Oncology. 2007-03-01 - 327 citationsInduction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.Rafael Winograd, Katelyn T. Byrne, Rebecca A. Evans, Pamela M. Odorizzi, Anders R.L. Meyer
Cancer Immunology Research. 2015-04-01
Press Mentions
- Combining Two Cancer Drugs Can Be Effective in Treating Specific Type of Colorectal Cancer, Study ShowsMay 2nd, 2022
- Adoptive Cell TherapyDecember 12th, 2018
- Immunotherapy Combo Appears Safe, Shrinks Metastatic Melanoma TumorsJune 2nd, 2015
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: